Skip to main content
Equibles

MetLife Investment Management, LLC

Position in AMGN — Amgen Inc

CIK 1529735 Whippany, NJ
Back to AMGN Full portfolio

Position in AMGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$50,143,480
-$425,105 QoQ
Shares Held
138,472
-3.7% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#220
of 3,155 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMGN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $750,511,239 across 12 Drug Manufacturers - General names. AMGN ranks #5 (6.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 212,458 $254,828,520
2 JNJ
Johnson & Johnson
 550,760 $139,876,517
3 ABBV
AbbVie Inc.
 409,814 $103,125,594
4 MRK
Merck & Co., Inc.
 565,110 $72,616,635
5 AMGN
Amgen Inc
This page 		138,472 $50,143,480
6 GILD
Gilead Sciences, Inc.
 284,053 $35,887,256
7 PFE
Pfizer Inc
 1,303,824 $31,396,081
8 AZN
Astrazeneca PLC
 149,538 $28,355,395

All Filings in AMGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $50,143,480 138,472
2026-03-31 $50,568,585 143,722
2025-12-31 $48,510,615 148,210
2025-09-30 $42,994,863 152,356
2025-03-31 $49,133,927 157,708
2024-12-31 $41,878,332 160,675
2024-09-30 $51,145,682 158,734
2024-06-30 $50,761,564 162,463
2024-03-31 $39,884,409 140,280
2023-12-31 $41,726,609 144,874
2023-09-30 $39,624,093 147,433
2023-06-30 $33,471,513 150,759
2023-03-31 $37,645,310 155,720
2022-12-31 $40,930,868 155,844
2022-09-30 $35,887,286 159,216
2022-06-30 $39,156,215 160,938
2022-03-31 $41,667,278 172,307
2021-12-31 $27,677,384 123,027
2021-09-30 $26,881,937 126,414
2021-06-30 $32,014,612 131,342
2021-03-31 $33,778,943 135,762
2020-12-31 $32,072,230 139,493
2020-09-30 $37,251,977 146,569
2020-06-30 $35,982,094 152,557
2020-03-31 $31,049,924 153,159